Setting the optimal threshold of NT-proBNP and BNP for the diagnosis of heart failure in patients over 75 years.
Emmanuelle BerthelotMinh Tam BaillyXenia Cerchez LehovaManel El Blidi RahmaniRahil BounabNathan MewtonJohn E DobbsRemy MasMarie FrankNicolas LelloucheMarion PaclotPatrick JourdainPublished in: ESC heart failure (2024)
In older patients, we found significant effects of co-morbidities on natriuretic peptides results, particularly in patients over 85 years old, older patients with abnormal renal function, obesity, and atrial fibrillation. Despite the consideration of those co-morbid conditions, NT-proBNP and BNP level continue to demonstrate utility in the diagnosis of AHF in older patients.
Keyphrases
- heart failure
- end stage renal disease
- ejection fraction
- atrial fibrillation
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- insulin resistance
- bariatric surgery
- body mass index
- left ventricular
- adipose tissue
- left atrial
- skeletal muscle
- venous thromboembolism
- catheter ablation
- acute coronary syndrome
- direct oral anticoagulants
- patient reported
- high fat diet induced